Edition:
United States

Profile: Abbott Laboratories (ABT)

ABT on New York Consolidated

52.51USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$52.51
Open
$51.51
Day's High
$52.58
Day's Low
$51.50
Volume
7,978,960
Avg. Vol
5,765,910
52-wk High
$52.60
52-wk Low
$37.38

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Company Address

Abbott Laboratories

100 Abbott Park Rd
ABBOTT PARK   IL   60064-3500
P: +1847.9376100

Company Web Links